Track the RCM Technologies, INC. share price and the full management transaction log of the company, a listed issuer based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). Operating in the Industry sector, RCM Technologies, INC. has recorded 69 public disclosures. Market capitalisation: €163.9m. The latest transaction was filed on 18 March 2025 (Cession). Among the most active insiders: Vizi Bradley. Every trade is free.
Analysts rate RCM Technologies, INC. Strong Buy (bullish), based on 2 analysts. Average price target: US$38.00.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
25 of 69 declarations
RCM Technologies, Inc. (Nasdaq: RCMT) is a U.S.-listed business services and technology solutions company traded on the American market within the NYSE/NASDAQ universe. Headquartered in Pennsauken, New Jersey, United States, the company traces its roots back to 1971. RCM is not a pure software vendor; rather, it is a diversified services provider that combines engineering expertise, specialized staffing, and transformation-oriented technology services for industrial, healthcare, and institutional clients. Today, RCM Technologies is organized into three operating segments: Engineering; Specialty Health Care; and Life Sciences, Data & Solutions. The Engineering segment provides applied engineering, project execution, design support, and technical solutions for complex environments, with exposure to aerospace and defense, energy, critical infrastructure, and process and industrial markets. Specialty Health Care delivers healthcare staffing solutions, including nurses, therapists, medical professionals, health information management specialists, and other clinical talent, serving major healthcare institutions and school districts across the United States. Life Sciences, Data & Solutions focuses on business modernization, data-driven process improvement, and technology-enabled services for life sciences and other mission-critical end markets. From a competitive standpoint, RCM operates in niches where sector depth, speed of delivery, and access to hard-to-find talent matter more than scale alone. Its mid-cap profile gives it more flexibility than a large systems integrator while still providing diversification across several end markets. The company has a primarily domestic footprint in the United States, but it also operates in Canada, Puerto Rico, Europe, Germany, and the Philippines. That said, the majority of revenue is generated in the United States. Recent company communications in 2025 and 2026 indicate continued activity across project execution and the positioning of its engineering, specialty healthcare, and data solutions capabilities. For equity investors, RCM also attracts attention through SEC Form 4 insider transaction filings, which show recurring activity at the management and controlling-shareholder level. Overall, RCM Technologies remains a diversified small-cap services name with long operating history, a broad but focused service portfolio, and meaningful exposure to staffing and project-based demand cycles.